Skip to content

Postural responses to balance perturbations in individuals with Supratentorial Stroke and Idiopathic Parkinson's Disease

Postural responses to balance perturbations in individuals with Supratentorial Stroke and Idiopathic Parkinson's Disease - Posture Stroke PD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON36220
Enrollment
30
Registered
2011-04-07
Start date
2011-05-01
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease Stroke

Interventions

None listed

Sponsors

Universitair Medisch Centrum Sint Radboud
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: All participants: - Functional Ambulation Categories 3-5 - Age 18 years and older - Ability to stand independently (on bare feet) for at least 30 minutes Stroke patients: - Unilateral Supratentorial Stroke longer than 6 months ago Parkinson patients: - Idiopathic Parkinson's Disease - Hoehn & Yahr Stages 1-3

Exclusion criteria

Exclusion criteria: - Any other neurological or musculoskeletal disorder affecting balance - Any inability to cooperate with the assessments and to give written informed consent - Medication negatively affecting balance (e.g. neuroleptics, antidepressants, anticonvulsants, sedatives).

Design outcomes

Primary

MeasureTime frame
The stepping threshold, defined as the highest perturbation intensity (in m/s2) at which balance is maintained with a feet in place response.

Secondary

MeasureTime frame
- Kinematic variables such as joint angles and Centre of Mass (CoM) - Margin of Stability defined as the minimum distance between the vertical projection of the CoM and the border of the Base of Support (BoS) during perturbations at the stepping threshold. - EMG (electromyographic) variables such as onset latency and amplitude.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)